Lawrence A. Cone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lawrence A. Cone has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Carlos Lopez
4 shared publicationsJoel Hirschberg
Department of Medicine, Eisenhower Medical Center, Rancho Mirage, CA 92270, USA
3 shared publicationsRadhika Gade-Andavolu
Genetic Research Institute of the Desert, Rancho Mirage, CA 92270, USA
3 shared publicationsAsma Kazi
2 shared publicationsBachir Younes
Department of Medicine, Eisenhower Medical Center, Rancho Mirage, CA 92270, USA
2 shared publicationsBarbara E. Potts
Department of Medicine, Eisenhower Medical Center, Rancho Mirage, California; Department of Medicine, Palo Verde Hospital, Blythe, Bighorn Institute, Palm Desert, California
2 shared publications
Latest Publications
- 1 November 2008
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 12 (6) , 578-581
Unusual infections due to Listeria monocytogenes in the Southern California Desert
- 1 November 2008
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 12 (6) , 578-581
Unusual infections due to Listeria monocytogenes in the Southern California Desert
- 1 June 2008
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 14 (3) , 181-182
Staphylococcal Septic Arthritis of the Small Joints of the Shoulder Girdle
- 1 June 2008
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 14 (3) , 181-182
Staphylococcal Septic Arthritis of the Small Joints of the Shoulder Girdle
- 1 February 2008
- Published by Elsevier in Surgical Neurology
- Vol. 69 (2) , 121-125
Infective endocarditis associated with spondylodiscitis and frequent secondary epidural abscess
- 1 February 2008
- Published by Elsevier in Surgical Neurology
- Vol. 69 (2) , 121-125
Infective endocarditis associated with spondylodiscitis and frequent secondary epidural abscess
- 1 November 2007
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 15 (6) , 403-405
Chryseobacterium indologenes Sepsis Due to an Infected Central Catheter in a Patient With Metastatic Breast Cancer to the Skin
Chryseobacterium indologenes, previously called Flavobacterium, has been reported to cause hospital-acquired infections mostly in Taiwan but rarely elsewhere. Six cases have been recorded in Europe, 2 in Australia, and a single case in the United States. We report a second case in the United States in a patient with metastatic breast cancer who, while on chemotherapy, developed a bacteremia due to C. indologenes via an indwelling catheter. Initially described as a gram-negative rod, this led to treatment with carbapenems to which the isolate proved resistant. Once the definitive speciation and in vitro sensitivities became available, appropriate antimicrobial therapy led to resolution of the infection. Broth microdilution rather than disc diffusion correlates most accurately with minimum inhibitory concentrations.
- 1 November 2007
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 15 (6) , 403-405
Chryseobacterium indologenes Sepsis Due to an Infected Central Catheter in a Patient With Metastatic Breast Cancer to the Skin
Chryseobacterium indologenes, previously called Flavobacterium, has been reported to cause hospital-acquired infections mostly in Taiwan but rarely elsewhere. Six cases have been recorded in Europe, 2 in Australia, and a single case in the United States. We report a second case in the United States in a patient with metastatic breast cancer who, while on chemotherapy, developed a bacteremia due to C. indologenes via an indwelling catheter. Initially described as a gram-negative rod, this led to treatment with carbapenems to which the isolate proved resistant. Once the definitive speciation and in vitro sensitivities became available, appropriate antimicrobial therapy led to resolution of the infection. Broth microdilution rather than disc diffusion correlates most accurately with minimum inhibitory concentrations.
- 1 March 2007
- Published by Elsevier in Surgical Neurology
- Vol. 67 (3) , 296-297
Brain abscess due to Streptococcus acidominimus: first case report
- 1 March 2007
- Published by Elsevier in Surgical Neurology
- Vol. 67 (3) , 296-297
Brain abscess due to Streptococcus acidominimus: first case report
- 1 August 2006
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 75 (2) , 315-317
THE SEROLOGIC PREVALENCE OF Q FEVER (COXIELLA BURNETII) COMPLEMENT-FIXING ANTIBODIES IN THE PENINSULAR BIGHORN SHEEP OF SOUTHERN CALIFORNIA
Q fever is a rare illness in the Southern California desert. During the past 34 years only 6 patients have been diagnosed with the disease at the Eisenhower Medical Center, a referral center for much of the desert and surrounding mountains. In all but 2 instances, Q fever was identified in patients who have been in contact with imported domestic sheep who are brought to the desert to graze and lamb in the fall and winter. The sheep are sent back to Idaho, Wyoming, and Montana in the spring. With frequent infection by Coxiella burnetii established in domestic sheep, we elected to study the prevalence of complement fixing antibodies to Coxiella burnetii in native bighorn sheep who reside in the lower levels of the mountains surrounding the desert. From 1992 to 1999, of 268 serum samples drawn from male and female lambs and adult sheep, 27 tested positive (10%), which is strikingly low when compared with Dall sheep in Alaska (12 of 15), kangaroos, wild rabbits, and brown rats. Because changes have been made in Peninsular bighorn sheep habitat since the animals were listed as endangered in 1998, further follow-up in Q fever serology testing will be of interest.
- 1 August 2006
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 75 (2) , 315-317
THE SEROLOGIC PREVALENCE OF Q FEVER (COXIELLA BURNETII) COMPLEMENT-FIXING ANTIBODIES IN THE PENINSULAR BIGHORN SHEEP OF SOUTHERN CALIFORNIA
Q fever is a rare illness in the Southern California desert. During the past 34 years only 6 patients have been diagnosed with the disease at the Eisenhower Medical Center, a referral center for much of the desert and surrounding mountains. In all but 2 instances, Q fever was identified in patients who have been in contact with imported domestic sheep who are brought to the desert to graze and lamb in the fall and winter. The sheep are sent back to Idaho, Wyoming, and Montana in the spring. With frequent infection by Coxiella burnetii established in domestic sheep, we elected to study the prevalence of complement fixing antibodies to Coxiella burnetii in native bighorn sheep who reside in the lower levels of the mountains surrounding the desert. From 1992 to 1999, of 268 serum samples drawn from male and female lambs and adult sheep, 27 tested positive (10%), which is strikingly low when compared with Dall sheep in Alaska (12 of 15), kangaroos, wild rabbits, and brown rats. Because changes have been made in Peninsular bighorn sheep habitat since the animals were listed as endangered in 1998, further follow-up in Q fever serology testing will be of interest.
- 1 August 2006
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 12 (4) , 187-189
Staphylococcal Septic Synovitis of the Sternoclavicular Joint With Retrosternal Extension
Bacterial arthritis of the sternoclavicular joint is an uncommon disorder caused by a variety of microorganisms. Both Gram-positive and Gram-negative bacteria have been identified as etiologies of an acute suppurative arthritis, whereas a few other bacteria such as mycobacteria and treponemes have been incriminated in chronic disease of the sternoclavicular joint. We recently treated a patient with staphylococcal synovitis of the sternoclavicular joint, which is the 24th recorded in the literature. His illness was complicated by a retrosternal abscess, soft tissue abscess of the chest, septic bursitis, and lumbosacral discitis. He recovered after 6 weeks of nafcillin therapy without any residual infection. Six previous patients with extension into the substernal space and mediastinum have been described. Staphylococcal infection of the sternoclavicular joint, although usually confined to the joint, can be associated with sepsis and metastatic abscess formation as well as substernal extension even in immunocompetent individuals.
- 1 August 2006
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 12 (4) , 187-189
Staphylococcal Septic Synovitis of the Sternoclavicular Joint With Retrosternal Extension
Bacterial arthritis of the sternoclavicular joint is an uncommon disorder caused by a variety of microorganisms. Both Gram-positive and Gram-negative bacteria have been identified as etiologies of an acute suppurative arthritis, whereas a few other bacteria such as mycobacteria and treponemes have been incriminated in chronic disease of the sternoclavicular joint. We recently treated a patient with staphylococcal synovitis of the sternoclavicular joint, which is the 24th recorded in the literature. His illness was complicated by a retrosternal abscess, soft tissue abscess of the chest, septic bursitis, and lumbosacral discitis. He recovered after 6 weeks of nafcillin therapy without any residual infection. Six previous patients with extension into the substernal space and mediastinum have been described. Staphylococcal infection of the sternoclavicular joint, although usually confined to the joint, can be associated with sepsis and metastatic abscess formation as well as substernal extension even in immunocompetent individuals.
- 1 July 2006
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 14 (4) , 217-220
A Durable Response to Relapsing Clostridium difficile Colitis May Require Combined Therapy with High-dose Oral Vancomycin and Intravenous Immune Globulin
Background: Recurrent Clostridium difficile antimicrobial-induced diarrhea follows initial successful therapy with metronidazole or oral vancomycin in 5% to 65% of patients. Specific antibody formation to Toxin A of C. difficile has been found in those patients who remain asymptomatic or experience a single episode of diarrhea after their initial infection. Because those individuals who often cannot produce specific antibody develop relapsing colitis, we administered intravenous immune globulin (IVIG) to 20 such hospitalized patients and evaluated their responses. Materials and Methods: C. difficile immunoglobulin G antibody was measured in 18 of 20 patients with recurrent colitis using an enzyme-linked immunosorbent assay. All patients were subsequently placed on oral vancomycin (dosage, 500 mg 3 times a day) and 2 doses of IVIG (dosage, 30 g within 24 to 96 hours after antibody levels were drawn). The time interval between both doses was about 24 hours. Results: Eighteen of 20 patients had a durable response to the previously mentioned therapy, of which 1 case recurred within a 3-month follow-up period. Two patients responded to therapy but died of underlying or associated disease (one of pneumonia and one of congestive heart failure). Ten patients also received oral Saccharomyces boulardii, a nonpathogenic yeast. One of these patients died of heart failure and another had a recurrent disease. Conclusions: IVIG and high-dose oral vancomycin may be an effective regimen in eradicating relapsing C. difficile colitis, probably confirming the suspicion that patients who develop the disease lack the ability to produce adequate quantities of neutralizing immunoglobulin G antibody against Toxin A. Oral S. boulardii may help maintain freedom from relapse, which, however, was not confirmed in this study, and its use could be complicated by fungemia.
- 1 July 2006
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 14 (4) , 217-220
A Durable Response to Relapsing Clostridium difficile Colitis May Require Combined Therapy with High-dose Oral Vancomycin and Intravenous Immune Globulin
Background: Recurrent Clostridium difficile antimicrobial-induced diarrhea follows initial successful therapy with metronidazole or oral vancomycin in 5% to 65% of patients. Specific antibody formation to Toxin A of C. difficile has been found in those patients who remain asymptomatic or experience a single episode of diarrhea after their initial infection. Because those individuals who often cannot produce specific antibody develop relapsing colitis, we administered intravenous immune globulin (IVIG) to 20 such hospitalized patients and evaluated their responses. Materials and Methods: C. difficile immunoglobulin G antibody was measured in 18 of 20 patients with recurrent colitis using an enzyme-linked immunosorbent assay. All patients were subsequently placed on oral vancomycin (dosage, 500 mg 3 times a day) and 2 doses of IVIG (dosage, 30 g within 24 to 96 hours after antibody levels were drawn). The time interval between both doses was about 24 hours. Results: Eighteen of 20 patients had a durable response to the previously mentioned therapy, of which 1 case recurred within a 3-month follow-up period. Two patients responded to therapy but died of underlying or associated disease (one of pneumonia and one of congestive heart failure). Ten patients also received oral Saccharomyces boulardii, a nonpathogenic yeast. One of these patients died of heart failure and another had a recurrent disease. Conclusions: IVIG and high-dose oral vancomycin may be an effective regimen in eradicating relapsing C. difficile colitis, probably confirming the suspicion that patients who develop the disease lack the ability to produce adequate quantities of neutralizing immunoglobulin G antibody against Toxin A. Oral S. boulardii may help maintain freedom from relapse, which, however, was not confirmed in this study, and its use could be complicated by fungemia.
- 1 July 2006
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 75 (1) , 29-32
Q FEVER IN THE SOUTHERN CALIFORNIA DESERT: EPIDEMIOLOGY, CLINICAL PRESENTATION AND TREATMENT
Despite the absence of a natural reservoir for Q fever in the desert of Southern California, six cases have been identified during the past 32 years. During that period of time, two areas have been used by northern sheep ranchers from Idaho and Wyoming to import sheep to an area in the Coachella Valley through 1985. Thereafter, because of housing development, the sheep area was moved to Blythe along the Colorado River. All but two of these patients probably acquired infection by Coxiella burnetii by living or working in close proximity to these grazing areas but not directly involved with the sheep. The shift of infected patients from the Coachella Valley to Blythe (100 miles distant) seems to support that supposition. All patients with acute Q fever developed antibodies primarily to phase II antigen, whereas the only person with chronic Q fever developed phase I antibodies. All patients presented with granulomatous hepatitis. One also had a pulmonary infiltrate, and the single individual with chronic Q fever also had a mitral valve prosthesis, although echocardiography could not define endocarditis. All patients with acute infections responded to 3–5 weeks of therapy with doxycycline, whereas the patient with chronic disease failed 3 years of therapy with combination regimens. Further studies at the Eisenhower Medical Center on the prevalence of infection in Blythe, CA, and elsewhere are anticipated.
- 1 July 2006
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 75 (1) , 29-32
Q FEVER IN THE SOUTHERN CALIFORNIA DESERT: EPIDEMIOLOGY, CLINICAL PRESENTATION AND TREATMENT
Despite the absence of a natural reservoir for Q fever in the desert of Southern California, six cases have been identified during the past 32 years. During that period of time, two areas have been used by northern sheep ranchers from Idaho and Wyoming to import sheep to an area in the Coachella Valley through 1985. Thereafter, because of housing development, the sheep area was moved to Blythe along the Colorado River. All but two of these patients probably acquired infection by Coxiella burnetii by living or working in close proximity to these grazing areas but not directly involved with the sheep. The shift of infected patients from the Coachella Valley to Blythe (100 miles distant) seems to support that supposition. All patients with acute Q fever developed antibodies primarily to phase II antigen, whereas the only person with chronic Q fever developed phase I antibodies. All patients presented with granulomatous hepatitis. One also had a pulmonary infiltrate, and the single individual with chronic Q fever also had a mitral valve prosthesis, although echocardiography could not define endocarditis. All patients with acute infections responded to 3–5 weeks of therapy with doxycycline, whereas the patient with chronic disease failed 3 years of therapy with combination regimens. Further studies at the Eisenhower Medical Center on the prevalence of infection in Blythe, CA, and elsewhere are anticipated.
- 1 April 2006
- Published by Elsevier in Surgical Neurology
- Vol. 65 (4) , 372-375
Leptomeningeal carcinomatosis in a patient with metastatic prostate cancer: case report and literature review
- 1 April 2006
- Published by Elsevier in Surgical Neurology
- Vol. 65 (4) , 372-375
Leptomeningeal carcinomatosis in a patient with metastatic prostate cancer: case report and literature review